medline.ch Respirationstrakt Neoplasie

	Non-targeted metabolomics reveals diagnostic biomarker in the plasma of patients with lung cancer. Oncol Lett Liu Y, Li Y, Hou H, Dong Y, Tian H, Zhao Y, Li K, Zhou J, Song F, Li Y. PMID: 41235360 [PubMed]
	International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer. Front Public Health Tang D, Zou X, Wei C, Zhang X. PMID: 41235190 [PubMed - indexed for MEDLINE]
	Study of non-surgical therapeutic patterns and prognosis in elderly patients with stage II non-small-cell lung cancer: an investigational study based on the SEER database. Transl Cancer Res Zhang L, Xu X, Gao Y. PMID: 41234893 [PubMed]
	Integration of single-cell and bulk transcriptomics to explore prognostic and immunotherapeutic characteristics of sodium overload-induced cell death in lung adenocarcinoma. Transl Cancer Res Shi Y, Qu X, Liu D, Zhang H, Wang S, Song J, Wang L, Wang W. PMID: 41234862 [PubMed]
	Advances and challenges in circulating tumor DNA-based early detection of lung cancer. Transl Cancer Res Yoon JK, Park JY, Kim YW, Oh HJ, Kim YC. PMID: 41234819 [PubMed]
	Development and validation of machine learning models for predicting STAS in stage I lung adenocarcinoma with part-solid and solid nodules: a two-center study. Front Oncol Ren QL, Lin L, Chu K, Xu XR, Wang HJ, Wu J, You JZ, Hu JX, Wang XL, Shu YS. PMID: 41234731 [PubMed]
	Fusion of CT radiomics and autoantibody biomarkers for enhanced prediction of lung cancer diagnosis: a comprehensive study. Front Oncol Xia X, Liu J, Du Y, Ma X, Zhou G, Yuan J, Hua Q, Wang L, Jiang H, He C, Liu C. PMID: 41234728 [PubMed]
	Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers. Transl Lung Cancer Res Zhao X, Wu X, Wang H, Yu H, Sun S, Hu Z, Lin Y, Zhang Y, Yu B, Wu Z, Xiong K, Liu C, Wang S, Bao H, Ou Q, Wang J. PMID: 41234598 [PubMed]
	Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study. Transl Lung Cancer Res Du Y, Li Y, Yu M, Yu Y, Zhang Y, Wang X, He J, Lin L, Shen B, Gong Y, Zhu J, Zou B, Liu Y, Huang M, Lu Y. PMID: 41234596 [PubMed]
	Overall survival and progression-free survival of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany-a population-based cancer registry cohort study. Transl Lung Cancer Res Bertram S, Schliemann A, Katalinic A, Kim-Wanner SZ, Pritzkuleit R, Twardella D, Waldmann A. PMID: 41234592 [PubMed]
	Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial. Transl Lung Cancer Res Kim MH, Seong H, Kim SH, Eom JS. PMID: 41234591 [PubMed]
	The role of TRPA1 in lung cancer. Transl Lung Cancer Res O'Connor D, Finn SP, Gray SG. PMID: 41234585 [PubMed]
	A retrospective cross-sectional study of FGFR2b alterations in Chinese patients with advanced squamous non-small cell lung cancer: prevalence, programmed death-ligand 1 co-expression patterns, and association with clinical outcomes. Transl Lung Cancer Res Wang X, Chi K, Wang H, Sun S, Ao C, Li J, Ge Y, Yang C, Fu Y, Lin D, Tang R, Sun W. PMID: 41234584 [PubMed]
	Immune-oncology-microbiome axis in lung cancer: from carcinogenesis to therapy-a narrative review. Transl Lung Cancer Res Shen M, Chen Y, Chen J, Yin J, Xu C, Wang D, Lv T. PMID: 41234582 [PubMed]
	Characterization of RET fusions via integrated DNA and RNA sequencing in early-stage non-small cell lung cancer: a retrospective study. Transl Lung Cancer Res Ding Y, Chen G, He X, Shi Y, He C, Yin JC, Zhang Z. PMID: 41234581 [PubMed]
	Survival after wedge resection, segmentectomy and lobectomy for clinical stage IA non-small cell lung cancer: a systematic review and network meta-analysis. Transl Lung Cancer Res Sun C, Jin J, Chen J, Liu H, Witharana P, Yang M, Wang Z, Zhang Y, Sheng P, Chen Y, Zhu C, Shen J. PMID: 41234580 [PubMed]
	Influencing factors and prediction of growth heterogeneity in solid nodule non-small cell lung cancer based on artificial intelligence: a prospective study. Transl Lung Cancer Res Chen J, Liu J, Qi L, Li F, Cui S, Wang J. PMID: 41234577 [PubMed]
	Time toxicity in previously untreated metastatic or unresectable epidermal growth factor receptor-mutant non-small cell lung cancer: a clinical practice review. Transl Lung Cancer Res Jeon WJ, Joung B, Katikaneni PS, Chitkara A, Agrawal N, Padmaraju K, Ya N, Sadrameli S, Desai A, Chen E, Cetnar J, Thawani R. PMID: 41234573 [PubMed]
	Diagnostic utility of cryobiopsy for invasive mucinous lung adenocarcinoma. Transl Lung Cancer Res Kosuge A, Matsumoto Y, Furuse H, Sato K, Kashima J, Kishikawa S, Yotsukura M, Haruki T, Yoshida Y, Watanabe SI, Yatabe Y, Tsuchida T. PMID: 41234572 [PubMed]
	Deep learning radiomics and (18)F-FDG PET/CT imaging: mediastinal lymph node characteristics as predictors of metastasis in non-small cell lung cancer. Transl Lung Cancer Res Duan F, Zu H, Zhang R, Li Y, Zhao Y, Wang X, Zhang M, Li P, Wang D. PMID: 41234569 [PubMed]

Artikel 1 - 20 / 152465

Seite 1 von 7624



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung